Arthur Gulick, MD
Dermatology · Plymouth, MINPI 1730148065
Payments from drug & device makers
Across 134 payments — averaging $20.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$589
- Regeneron Healthcare Solutions, Inc.$266
- Lilly USA, LLC$251
- Sanofi$241
- AbbVie$229
- Novartis$200
- plus $944 from 23 others
What the payments were for
- Food & beverage$2,720100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 30 | $589 |
| Regeneron Healthcare Solutions, Inc. | 12 | $266 |
| Lilly USA, LLC | 12 | $251 |
| Sanofi | 11 | $241 |
| AbbVie | 12 | $229 |
| Novartis | 10 | $200 |
| Sun Pharmaceutical Industries Inc. | 5 | $109 |
| Boehringer Ingelheim | 4 | $109 |
| Pfizer | 5 | $95 |
| LEO Pharma Inc. | 4 | $63 |
| E.r. Squibb & Sons, L.L.C. | 2 | $47 |
| UCB, Inc. | 2 | $47 |
| Biofrontera Inc. | 3 | $47 |
| Incyte Corporation | 2 | $45 |
| Krystal Biotech Inc | 2 | $40 |
| Mylan Institutional Inc. | 2 | $39 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| Fresenius Kabi USA, LLC | 1 | $31 |
| Kerecis Limited | 1 | $29 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $29 |
| Merck | 2 | $25 |
| Blueprint Medicines Corporation | 1 | $23 |
| Organon | 1 | $23 |
| Dermira, Inc. | 1 | $23 |
| Dermavant Sciences, Inc. | 1 | $20 |
| Journey Medical Corporation | 1 | $17 |
| Almirall LLC | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $15 |
How this compares
$2,720 in reported general payments places this provider in the 45th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 56 | $2,560 |
| Ketoconazole | 61 | $1,275 |
| Desonide | 38 | $1,096 |
| Metronidazole | 13 | $720 |
| Doxycycline Hyclate | 29 | $681 |
| Ciclopirox | 26 | $514 |
| Clindamycin Phosphate | 18 | $429 |
| Triamcinolone Acetonide | 72 | $343 |
| Clobetasol Propionate | 16 | $334 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Plymouth
- Johann GudjonssonAnn Arbor$15.9M
- Ali MoiinTroy$9.9M
- Linda Stein GoldWest Bloomfield$7.5M
- Wendy McFaldaClarkston$3.6M
- Kristi HawleyCaledonia$2.5M
- Brent BoyceSebewaing$2.2M
- David AltmanWarren$1.9M
- Christofer BuattiAuburn Hills$1.6M
- Mio NakamuraAnn Arbor$1.4M
- George MurakawaTroy$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.